RecallDepth
Class II Terminated

Moxifloxacin Ophthalmic Solution USP 0.5%, 3 mL, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 Dist. By Aurobindo Pharma USA, Inc. East Windsor, NJ 08520, NDC 72189-076-05

Company
Direct Rx
Recall Initiated
February 17, 2022
Posted
March 9, 2022
Recall Number
D-0637-2022
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
44 bottles
Firm Location
Dawsonville, GA, United States

Reason for Recall

Failed impurities/degradation specifications

Distribution

Florida

Lot / Code Info

Lot#: 18JA2218 Exp. 6/30/23; 20DE2104 Exp. 6/30/23; 08NO2111 Exp. 6/30/23

More recalls by Direct Rx

View all recalls by this company →

Other recent Class II Drug recalls